Latest Breaking News On - Ncluding azn gb0009895292 - Page 1 : comparemela.com

By Michael Susin AstraZeneca PLC said Thursday that it has completed an exclusive global license agreement with KYM Biosciences over the CMG901 treatment for solid tumors, including gastric. | March 30, 2023

Keymed biosciencesLepu biopharmaMichael susinDow jonesAstrazeneca plc stock exchangePress releaseNcluding azn gb0009895292